Preferences help
enabled [disable] Abstract
Number of results
2015 | 86 | 3 | 151-157
Article title

Cell Adhesion Molecules in Terms of Carcinogenesis

Title variants
Languages of publication
Physical description
1 - 3 - 2014
12 - 2 - 2014
25 - 4 - 2014
  • 1. Paschos KA , Canovas D, Bird NC : The role of cell adhesion molecules in the progression of colorectal cancer and the development of liver metastasis. Cell Signal 2009; 21(5): 665-74.[WoS][Crossref][PubMed]
  • 2. Mantur M, Wojszel J: Cząsteczki adhezyjne oraz ich udział w procesie zapalnym i nowotworowym. Pol Merk Lek 2008; 24(140): 177-80.
  • 3. Li DM , Feng YM : Signaling mechanism of cell adhesion molecules in breast cancer metastasis: potential therapeutic targets. Breast Cancer Res Treat 2011; 128(1): 7-21.[PubMed][Crossref][WoS]
  • 4. Boscacci RT, Pfeiffer F, Gollmer K et al.: Comprehensive analysis of lymph node stroma-expressed Ig superfamily members reveals redundant and nonredundant roles for ICAM-1, ICAM-2, and VCAM-1 in lymphocyte homing. Blood 2010; 116(6): 915-25.[WoS][Crossref][PubMed]
  • 5. Brooks SA , Lomax-Browne HJ, Carter TM et al.: Molecular interactions in cancer cell metastasis. Acta Histochem 2010; 112(1): 3-25.[Crossref][PubMed]
  • 6. Lawson C, Wolf S: ICAM-1 signaling in endothelial cells. Pharmacol Rep 2009; 61(1): 22-32.[Crossref][PubMed]
  • 7. Usami Y, Ishida K, Sato S et al.: Intercellular adhesion molecule-1 (ICAM-1) expression correlates with oral cancer progression and induces macrophage/ cancer cell adhesion. Int J Cancer 2013; 133(3): 568-78.[PubMed][Crossref]
  • 8. Cook-Mills JM , Marchese ME, Abdala-Valencia H: Vascular Cell Adhesion Molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants. Antioxid Redox Signal 2011; 15(6): 1607-38.[WoS][Crossref]
  • 9. Ahmed MM , Mohammed SH: Significance of intratumoral microvessel density quantification based on immunohistochemical detection of PECAM-1 and vWF in colorectal carcinoma from Iraqi patients. Indian J Pathol Microbiol 2010; 53(3): 439-46.[WoS][PubMed][Crossref]
  • 10. Alevizos L, Gomatos IP, Smparounis S et al.: Review of the molecular profile and modern prognostic markers for gastric lymphoma: How do they affect clinical practice? Can J Surg 2012; 55(2): 117-24.[PubMed][WoS]
  • 11. K obayashi M, Hoshino H, Suzawa K et al.: Two distinct lymphocyte homing systems involved in the pathogenesis of chronic inflammatory gastrointestinal diseases. Semin Immunopathol 2012; 34(3): 401-13.[WoS]
  • 12. Suzuki A, Kobayashi M, Matsuda K: Induction of high endothelial venule-like vessels expressing GlcNAc6ST-1-mediated L-selectin ligand carbohydrate and mucosal addressin cell adhesion molecule 1 (MAdCAM-1) in a mouse model of „Candidatus Helicobacter heilmannii”-induced gastritis and gastric mucosa-associated lymphoid tissue (MALT) lymphoma. Helicobacter 2010; 15(6): 538-48.[WoS]
  • 13. Thomas S, Baumgart DC : Targeting leukocyte migration and adhesion in Crohn’s disease and ulcerative colitis. Inflammopharmacology 2012; 20(1): 1-18.[Crossref][PubMed]
  • 14. van der Voort van Zijp J, Hoekstra HJ, Basson MD : Evolving management of colorectal cancer. World J Gastroenterol 2008; 14(25): 3956-67.[PubMed][WoS]
  • 15. Weller M, Stupp R, Hegi M et al.: Individualized targeted therapy for glioblastoma: fact or fiction? Cancer J 2012; 18(1): 40-44.[PubMed][Crossref]
  • 16. Sun W: Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy. J Hematol Oncol 2012; 5: 63.[Crossref][PubMed][WoS]
  • 17. Laeubli H, Borsig H: Selectins promote tumor metastasis. Semin Cancer Biol 2010; 20(3): 169-77.[Crossref]
  • 18. L ouderbough JM , Schroeder JA : Understanding the dual nature of CD44 in breast cancer progression. Mol Cancer Res 2011; 9(12): 1573-86.[WoS]
  • 19. Imrich S, Hachmeister M, Gires O: EpCAM and its potential role in tumor-initiating cells. Cell Adh Migr 2012; 6(1): 30-38.[Crossref][WoS][PubMed]
  • 20. Korja M, Jokilammi A, Salmi TT et al.: Absence of polysialylated NCAM is an unfavorable prognostic phenotype for advanced stage neuroblastoma. BMC Cancer 2009; 9: 57.[PubMed][WoS][Crossref]
  • 21. Kulahin N, Walmod PS: The neural cell adhesion molecule NCAM2/OCAM/RNCAM, a close relative to NCAM. Adv Exp Med Biol 2010; 663: 403-20.
  • 22. Tsanou E, Peschos D, Batistatou A et al.: The E-Cadherin Adhesion Molecule and Colorectal Cancer. A Global Literature Approach. Anticancer Res 2008; 28(6A): 3815-26.[PubMed]
  • 23. Paredes J, Correia AL , Ribeiro AS et al.: Pcadherin expression in breast cancer: a review. Breast Cancer Res 2007; 9(5): 214.[Crossref]
  • 24. Hibi K, Goto T, Mizukami H et al.: Demethylation of the CDH3 gene is frequently detected in advanced colorectal cancer. Anticancer Res 2009; 29(6): 2215-17.
  • 25. Yoshioka H, Yamamoto S, Hanaoka H et al.: In vivo therapeutic effect of CDH3/P-cadherin-targeting radioimmunotherapy. Cancer Immunol Immunother 2012; 61(8): 1211-20.[Crossref][WoS]
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.